Proteomics and Diabetic Nephropathy

Seminars in Nephrology

Volumn 27, Issue 6, 2007, Pages 627-636

  Merchant, Michael L ^a   Klein, Jon B ^a,b  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Biomarker; electrophoresis; liquid chromatography; mass spectrometry; urine

Indexed keywords

INSULIN; LEPTIN; STAT3 PROTEIN;

ARTICLE; DIABETIC NEPHROPATHY; ELECTROPHORESIS; ELECTROSPRAY MASS SPECTROMETRY; GENE THERAPY; GLOMERULONEPHRITIS; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY CORTEX; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEDICAL RESEARCH; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS;

ANIMALS; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; KIDNEY; PROTEINURIA; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 36549001613     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2007.09.003     Document Type: Article

References (35)

1. Susztak K., and Bottinger E.P. Diabetic nephropathy. a frontier for personalized medicine. J Am Soc Nephrol 17 (2006) 361-367
2. Rossing P. Diabetic nephropathy: worldwide epidemic and effects of current treatment on natural history. Curr Diab Rep 6 (2006) 479-483
3. Cohen P. The twentieth century struggle to decipher insulin signaling. Nat Rev Mol Cell Biol 7 (2006) 867-873
4. Tripathi B.K., and Srivastava A.K. Diabetes mellitus: complications and therapeutics. Med Sci Monit 12 (2006) RA130-RA147
5. Perkins BA, Ficociello LH, Ostrander BE, et al. Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes. J Am Soc Nephrol. 200;18:1353-61.
6. Perkins B.A., and Krolewski A.S. Early nephropathy in type 1 diabetes: a new perspective on who will and who will not progress. Curr Diab Rep 5 (2005) 455-463
7. Perkins B.A., Ficociello L.H., Silva K.H., et al. Regression of microalbuminuria in type 1 diabetes. N Engl J Med 348 (2003) 2285-2293
8. Kenyon G.L., DeMarini D.M., Fuchs E., et al. Defining the mandate of proteomics in the post-genomics era: workshop report. Mol Cell Proteomics 1 (2002) 763-780
9. Janech M.G., Raymond J.R., and Arthur J.M. Proteomics in renal research. Am J Physiol 292 (2007) F501-F512
10. Fliser D., Novak J., Thongboonkerd V., et al. Advances in urinary proteome analysis and biomarker discovery. J Am Soc Nephrol 18 (2007) 1057-1071
11. Issaq H.J., and Veenstra T.D. The role of electrophoresis in disease biomarker discovery. Electrophoresis 28 (2007) 1980-1988
12. Veenstra T.D. Global and targeted quantitative proteomics for biomarker discovery. J Chromatogr B Analyt Technol Biomed Life Sci 847 (2007) 3-11
13. Pisitkun T., Johnstone R., and Knepper M.A. Discovery of urinary biomarkers. Mol Cell Proteomics 5 (2006) 1760-1771
14. Hoorn E.J., Pisitkun T., and Zietse R. Prospects for urinary proteomics: exosomes as a source of urinary biomarkers. Nephrology (Carlton) 10 (2005) 283-290
15. Hewitt S.M., Dear J., and Star R.A. Discovery of protein biomarkers for renal diseases. J Am Soc Nephrol 15 (2004) 1677-1689
16. Wittke S., Fliser D., Haubitz M., et al. Determination of peptides and proteins in human urine with capillary electrophoresis-mass spectrometry, a suitable tool for the establishment of new diagnostic markers. J Chromatogr A 1013 (2003) 173-181
17. Fiedler G.M., Baumann S., Leichtle A., et al. Standardized peptidome profiling of human urine by magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chem 53 (2007) 421-428
18. Castagna A., Cecconi D., Sennels L., et al. Exploring the hidden human urinary proteome via ligand library beads. J Proteome Res 4 (2005) 1917-1930
19. Roelofsen H, Varez-Llamas G, Schepers M, et al. Proteomics profiling of urine with surface enhanced laser desorption/ionization time of flight mass spectrometry. Proteome Sci 207;5:2.
20. Wang L., Li F., Sun W., et al. Concanavalin A-captured glycoproteins in healthy human urine. Mol Cell Proteomics 5 (2006) 560-562
21. Sleat D.E., Zheng H., and Lobel P. The human urine mannose 6-phosphate glycoproteome. Biochim Biophys Acta 1774 (2007) 368-372
22. Thongboonkerd V., McLeish K.R., Arthur J.M., et al. Proteomic analysis of normal human urinary proteins isolated by acetone precipitation or ultracentrifugation. Kidney Int 62 (2002) 1461-1469
23. Pisitkun T., Shen R.F., and Knepper M.A. Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci U S A 101 (2004) 13368-13373
24. Adachi J., Kumar C., Zhang Y., et al. The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biol 7 (2006) R80
25. Zhang Y., Zhang Y., Adachi J., et al. MAPU: Max-Planck Unified database of organellar, cellular, tissue and body fluid proteomes. Nucleic Acids Res 35 (2007) D771-D779
26. Varghese S.A., Powell T.B., Budisavljevic M.N., et al. Urine biomarkers predict the cause of glomerular disease. J Am Soc Nephrol 18 (2007) 913-922
27. Sharma K., Lee S., Han S., et al. Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy. Proteomics 5 (2005) 2648-2655
28. Rao P.V., Lu X., Standley M., et al. Proteomic identification of urinary biomarkers of diabetic nephropathy. Diabetes Care 30 (2007) 629-637
29. Otu H.H., Can H., Spentzos D., et al. Prediction of diabetic nephropathy using urine proteomic profiling 10 years prior to development of nephropathy. Diabetes Care 30 (2007) 638-643
30. Meier M., Kaiser T., Herrmann A., et al. Identification of urinary protein pattern in type 1 diabetic adolescents with early diabetic nephropathy by a novel combined proteome analysis. J Diabetes Complications 19 (2005) 223-232
31. Mischak H., Kaiser T., Walden M., et al. Proteomic analysis for the assessment of diabetic renal damage in humans. Clin Sci (Lond) 107 (2004) 485-495
32. Rossing K., Mischak H., Parving H.H., et al. Impact of diabetic nephropathy and angiotensin II receptor blockade on urinary polypeptide patterns. Kidney Int 68 (2005) 193-205
33. Tilton R.G., Haidacher S.J., Lejeune W.S., et al. Diabetes-induced changes in the renal cortical proteome assessed with two-dimensional gel electrophoresis and mass spectrometry. Proteomics 7 (2007) 1729-1742
34. Diao W.F., Chen W.Q., Wu Y., et al. Serum, liver, and kidney proteomic analysis for the alloxan-induced type I diabetic mice after insulin gene transfer of naked plasmid through electroporation. Proteomics 6 (2006) 5837-5845
35. Kim H.J., Cho E.H., Yoo J.H., et al. Proteome analysis of serum from type 2 diabetics with nephropathy. J Proteome Res 6 (2007) 735-743